Trial · NCT00537680
Adverse events21
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 21
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Infections | Infections and infestations | Mid Dose Idebenone | 11 | 22 | |
| other | Infections | Infections and infestations | High Dose Idebenone | 15 | 24 | |
| other | Infections | Infections and infestations | Placebo | 16 | 24 | |
| other | Nervous system disorders | Nervous system disorders | Mid Dose Idebenone | 10 | 22 | |
| other | Nervous system disorders | Nervous system disorders | High Dose Idebenone | 14 | 24 | |
| other | Nervous system disorders | Nervous system disorders | Placebo | 12 | 24 | |
| other | Gastrointestinal disorders | Gastrointestinal disorders | Mid Dose Idebenone | 8 | 22 | |
| other | Gastrointestinal disorders | Gastrointestinal disorders | High Dose Idebenone | 15 | 24 | |
| other | Gastrointestinal disorders | Gastrointestinal disorders | Placebo | 12 | 24 | |
| other | General disorders | General disorders | Mid Dose Idebenone | 10 | 22 | |
| other | General disorders | General disorders | High Dose Idebenone | 9 | 24 | |
| other | General disorders | General disorders | Placebo | 9 | 24 | |
| other | Musculoskeletal & connective tissue disorders | Musculoskeletal and connective tissue disorders | Mid Dose Idebenone | 7 | 22 | |
| other | Musculoskeletal & connective tissue disorders | Musculoskeletal and connective tissue disorders | High Dose Idebenone | 10 | 24 | |
| other | Musculoskeletal & connective tissue disorders | Musculoskeletal and connective tissue disorders | Placebo | 7 | 24 | |
| serious | idiopathic thrombocytopenic purpura | Blood and lymphatic system disorders | Mid Dose Idebenone | 0 | 22 | 0 |
| serious | idiopathic thrombocytopenic purpura | Blood and lymphatic system disorders | High Dose Idebenone | 1 | 24 | 1 |
| serious | idiopathic thrombocytopenic purpura | Blood and lymphatic system disorders | Placebo | 0 | 24 | 0 |
| serious | chest pain | General disorders | Mid Dose Idebenone | 0 | 22 | 0 |
| serious | chest pain | General disorders | High Dose Idebenone | 1 | 24 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00537680/events